
Esi sikhokelo sibonelela ngolwazi olubanzi malunga ne-renal cell carcinoma (RCC), egxile kwi-prognosis kunye neendlela ezikhoyo zonyango. Siza kuphonononga izinto ezinefuthe kwi-prognosis, iindlela ezahlukeneyo zonyango, kunye nendlela yokufumana olona khathalelo lungcono kufutshane nawe. Funda malunga nenkqubela phambili yamva nje kunye nezixhobo zokuhamba kolu hambo lucelomngeni. Ukufumana isicwangciso sonyango esilungileyo kubalulekile, kwaye esi sikhokelo sijonge ukukuxhobisa ngolwazi oludingayo ukuze wenze izigqibo ezizizo.
I-Renal cell carcinoma, ekwabizwa ngokuba ngumhlaza wezintso, iqala kunwebu lwezintso. Lolona hlobo luqhelekileyo lomhlaza wezintso, olubalelwa malunga ne-90% yazo zonke ii-cancer zezintso. Ukufunyaniswa kwangoko kunye nonyango kubalulekile ekuphuculeni unyango lwe-renal cell carcinoma prognosis.
Inqanaba le-RCC ekuxilongweni lichaphazela kakhulu iprognosis. Iinkqubo zeStaging, ezifana ne-TNM system, zihlela amathumba ngokusekelwe kubukhulu, asasazeka kwii-lymph nodes ezikufutshane, kunye ne-metastasis ekude. Amanqanaba aphezulu abonisa ukungathandeki kangako iprognosis. Ulwazi oluthe vetshe malunga neqonga lunokufumaneka kwimithombo yonyango ehloniphekileyo njengeZiko leSizwe loMhlaza (NCI). Iziko lomhlaza leSizwe
Izinto ezininzi zichaphazela iprognosis ye renal cell carcinoma, kuquka:
Utyando luhlala lolona nyango luphambili lwe-RCC yendawo. Oku kunokubandakanya i-nephrectomy engaphelelanga (ukususwa kwethumba kunye nenxalenye yezintso) okanye i-radical nephrectomy (ukususwa kwezintso zonke). Ukhetho lotyando luxhomekeke kubungakanani bethumba, indawo, kunye nempilo yonke yesigulana.
Unyango ekujoliswe kulo lwenzelwe ukuhlasela iiseli ezithile zomhlaza ngaphandle kokonakalisa iiseli ezisempilweni. Olu nyango luhlala lusetyenziselwa i-RCC ephezulu okanye ye-metastatic. Imizekelo ibandakanya i-sunitinib, pazopanib, kunye ne-axitinib. Funda kabanzi malunga nonyango olujoliswe kuyo kwi-NCI.
I-Immunotherapy idibanisa amajoni omzimba ukulwa neeseli zomhlaza. I-immune checkpoint inhibitors, njenge-nivolumab kunye ne-ipilimumab, isetyenziswa ngokuqhelekileyo ukuphatha i-RCC ephezulu. Olu nyango lubonise impumelelo ebonakalayo ekuphuculeni iprognosis kwezinye izigulane.
Unyango ngemitha isebenzisa imiqadi enamandla kakhulu ukutshabalalisa iiseli zomhlaza. Ingasetyenziselwa ukukhulula iimpawu kwi-RCC ephezulu okanye njengenxalenye yendlela yonyango edibeneyo.
Ukufumana ukhathalelo lwengcali renal cell carcinoma ibalulekile. Kuya kufuneka udibane ne-oncologist eyingcali yomhlaza weurologic. Amaziko amaninzi ahloniphekileyo omhlaza anikezela ngeendlela zonyango eziphambili kunye nenkxaso ebanzi. Cinga ngokufuna uluvo lwesibini ukuze uqinisekise ukuba ufumana olona khathalelo lunokwenzeka.
I-oncologist yakho iya kubonelela ngomntu iprognosis ngokusekelwe kwimeko yakho ethile. Oku kubandakanya inqanaba lomhlaza wakho, impilo yakho iyonke, kunye nempendulo yakho kunyango. Ngelixa i iprognosis yeyona nto ibalulekileyo, kubalulekile ukukhumbula ukuba ayisongqikelelo eqinisekileyo, kwaye abantu abaninzi abane-RCC baphila ubomi obude nobanelisayo emva kokuxilongwa kunye nonyango.
Ukukhangela ukuxilongwa kwe renal cell carcinoma kunokuba lucelomngeni, ngokweemvakalelo nangokoqobo. Kubalulekile ukufuna inkxaso kwimithombo eyahlukeneyo, kubandakanywa:
Khumbula ukusoloko udibana nomboneleli wakho wezempilo ngeengcebiso ezenzelwe wena kunye neengcebiso zonyango. Le ngcaciso yenzelwe iinjongo zemfundo kuphela kwaye akufanele ithathwe njengengcebiso yezonyango.
ecaleni>
umzimba>